AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Summary
• IonQ’s Q3 revenue surged 222% to $39.9M, yet shares fell 11.4% post-earnings
• Skyloom acquisition sparks short-term rebound but fails to offset broader selloff
• Bollinger Bands signal oversold conditions as RSI dips to 32.9
• Options chain shows aggressive put buying ahead of Nov 28 expiration
IonQ’s volatile session reflects a tug-of-war between bullish fundamentals—$1.5B cash reserves, 99.99% gate fidelity—and persistent profitability concerns. The stock’s 8.2% drop to $43.95, despite a 222% revenue surge and strategic Skyloom acquisition, underscores investor skepticism. With Bollinger Bands pinching the price near the lower band and RSI in oversold territory, the selloff may present a tactical entry point for those betting on the company’s long-term quantum dominance.
Earnings Optimism Clashes With Profitability Realities
IonQ’s 11.4% post-earnings selloff stems from a stark disconnect between revenue growth and profitability. While Q3 revenue soared 222% to $39.9M—exceeding guidance by 37%—the company posted a $1.1B net loss and a 157.95 forward P/S ratio, dwarfing the sector’s 5.54 average. This gap between commercial progress (e.g., $1.5B cash reserves, DOE partnerships) and operational losses has triggered profit-taking and short-covering. The Skyloom acquisition, though bullish for quantum networking, failed to offset broader market doubts about near-term profitability, especially as the stock trades at a 68% discount to its 52-week high of $84.64.
Quantum Sector Volatility: IBM’s 1.27% Rally Contrasts IonQ’s Selloff
While
Options Playbook: Aggressive Puts and ETF Neutral Stance
• 200-day MA: $41.89 (below current price) | RSI: 32.9 (oversold) | MACD: -4.09 (bearish) | Bollinger Bands: $44.22–$66.28
• Short-term bearish trend confirmed by 32.9 RSI and -4.09 MACD; 200-day MA at $41.89 acts as critical support
• No leveraged ETF data available; focus on options for directional bets
Top Options Contracts:
• IONQ20251128P43 (Put):
- Strike: $43 | Expiry: 2025-11-28 | IV: 97.08% | Leverage: 19.85% | Delta: -0.4157 | Theta: -0.0511 | Gamma: 0.0583 | Turnover: 22,456
- IV (97.08%): High volatility implies strong price swings
- Leverage (19.85%): Amplifies downside potential
- Delta (-0.4157): Moderately sensitive to price drops
- Gamma (0.0583): Gains in value as price declines
- Turnover (22,456): High liquidity ensures easy entry/exit
- Payoff (5% downside to $41.75): $1.25 per contract (max gain if price < $43)
- Why it stands out: Balances leverage, liquidity, and gamma for a bearish play
• IONQ20251128P45 (Put):
- Strike: $45 | Expiry: 2025-11-28 | IV: 98.17% | Leverage: 13.25% | Delta: -0.5329 | Theta: -0.0269 | Gamma: 0.0588 | Turnover: 88,580
- IV (98.17%): Suggests extreme volatility
- Leverage (13.25%): Moderate downside exposure
- Delta (-0.5329): Strong sensitivity to price drops
- Gamma (0.0588): Accelerates in value as price declines
- Turnover (88,580): Exceptional liquidity
- Payoff (5% downside to $41.75): $3.25 per contract (max gain if price < $45)
- Why it stands out: High liquidity and delta make it ideal for aggressive bearish bets
Trading Setup: Aggressive short-side positioning via IONQ20251128P43 and IONQ20251128P45 is warranted. Key levels to watch: 200-day MA at $41.89 (support) and Bollinger Band lower bound at $44.22 (resistance). If $41.89 breaks, the 52-week low of $17.88 becomes a distant target. For bulls, a rebound above $49.57 (intraday high) could trigger a retest of the $55.25 20-day MA.
Backtest IonQ Stock Performance
It looks like the back-test engine stopped because the event-date file we generated did not contain any valid occurrences, so its internal statistics routine hit an empty-data edge case (“min() arg is an empty sequence”). Most likely causes:1. Our detection step required an “intraday drop of at least –8 % from the session high to the low”, but we only had daily OHLC data and the routine may have failed to recognise any qualifying dates (or the file structure lacked the raw High / Low / Open / Close fields the script expected).2. Because the resulting event-date list was empty, the event_backtest_engine could not compute any post-event returns.Recommended next steps (choose one):A) Re-detect events using daily Close-to-Close falls ≥ 8 %. • This relaxes the definition (close vs prior close) but guarantees we capture extreme down-days and lets us complete the analysis.B) Provide specific dates you regard as “–8 % intraday plunges” (if you already know them) and rerun the back-test with those manual dates.C) If you definitely need the true intraday (High→Low) criterion, we’ll have to fetch minute-level data for IONQ (larger data volume) and recompute the plunge dates, then rerun the back-test.Please let me know which option you prefer (A, B, or C), or give any additional requirements, and I’ll proceed accordingly.
Quantum Leap or Quantum Selloff? What to Watch Now
IonQ’s selloff reflects a market grappling with the tension between long-term quantum potential and near-term profitability. While the stock’s 8.2% drop has pushed it into oversold territory (RSI 32.9), the path forward hinges on two factors: 1) execution of the Skyloom acquisition to accelerate quantum networking, and 2) a reduction in the 157.95 forward P/S ratio through improved margins. Investors should monitor the 200-day MA at $41.89 and the $43.58 intraday low for directional clues. Meanwhile, IBM’s 1.27% rally as a sector leader underscores the importance of fault-tolerant progress. For now, the options market favors bearish plays, but a rebound above $49.57 could reignite optimism. Action Alert: Short-term traders should prioritize IONQ20251128P43 and IONQ20251128P45 for bearish exposure, while long-term holders may see this as a buying opportunity if $41.89 holds.

TickerSnipe provides professional intraday stock analysis using technical tools to help you understand market trends and seize short-term trading opportunities.

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.19 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet